Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01272921 · ClinicalTrials.gov registry record · Phase 4
The Use of Bupivacaine and Ropivacaine for Sciatic Nerve Block
A Phase 4 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 142
- Enrollment target
NCT01272921 is a Phase 4 study that has completed, run by Northwestern University. The registered enrollment target is 142 participants.
The verdict
NCT01272921, a Phase 4 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 142 participants
- Enrollment target
Study Summary
The duration of motor block for infragluteal parabiceps sciatic nerve block following total knee replacement may vary between 12-36 hrs depending on the amount of local anesthetic given.
Interventions
- DRUG Bupivacaine
- DRUG Ropivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2010-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01272921
The ClinicalTrials.gov registry entry for NCT01272921 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT01272921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01272921 about?
NCT01272921 is a clinical study titled "The Use of Bupivacaine and Ropivacaine for Sciatic Nerve Block". The duration of motor block for infragluteal parabiceps sciatic nerve block following total knee replacement may vary between 12-36 hrs depending on the amount of local anesthetic given.
What is the current status of trial NCT01272921?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 142 participants. The study started on 2010-11.
What interventions are being tested in trial NCT01272921?
The interventions under investigation include: Bupivacaine (DRUG), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT01272921?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.